3-O-[(9Z,12Z)-9,12-十八碳二烯酰基]-beta-D-呋喃果糖基alpha-D-吡喃葡萄糖苷 | 31835-02-6

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: 3-O-[(9Z,12Z)-9,12-十八碳二烯酰基]-beta-D-呋喃果糖基alpha-D-吡喃葡萄糖苷
• 英文名称: Sucrose (Z,Z)-9,12-octadecadienoate
• 英文别名: [(2S,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl (9Z,12Z)-octadeca-9,12-dienoate
• CAS: 31835-02-6
• 化学式: C₃₀H₅₂O₁₂
• 分子量: 604.7
• InChiKey: AUCZMVPHEMGJDJ-MVIOKFNFSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  42
• 可旋转键数：
  21
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  196
• 氢给体数：
  7
• 氢受体数：
  12

文献信息

• Reactive diluents and coatings comprising them
  申请人：Oostveen Arnoldus Evarardus

  公开号：US20050042379A1

  公开（公告）日：2005-02-24

  The invention relates to the use of a fatty acid modified carbohydrate obtainable by reaction of: (i) at least one carbohydrate or an acyl ester thereof; and (ii) a fatty acid, an alkyl ester thereof or a derivative thereof as a reactive diluent in a coating. The invention further relates to a coating which includes at least one binder and, as a reactive diluent, a fatty acid modified carbohydrate obtainable by reaction of (i) at least one carbohydrate or an acyl ester thereof; and (ii) a fatty acid, an alkyl ester thereof or a derivative thereof.

  该发明涉及使用一种脂肪酸改性的碳水化合物，其可通过以下反应获得：(i)至少一种碳水化合物或其酰基酯；和(ii)脂肪酸、其烷基酯或其衍生物作为涂层中的反应稀释剂。该发明还涉及一种涂层，其中包括至少一种粘合剂和作为反应稀释剂的脂肪酸改性的碳水化合物，其可通过以下反应获得：(i)至少一种碳水化合物或其酰基酯；和(ii)脂肪酸、其烷基酯或其衍生物。
• PERORAL IMMUNOGEN COMPOSITION AND PROCESS FOR PRODUCING THE SAME
  申请人：THE NISSHIN OIL MILLS, LTD.

  公开号：EP0775494A1

  公开（公告）日：1997-05-28

  The invention provides an immunogen composition for oral administration comprising an immunogen and one or more fatty acid esters of sucrose wherein the fatty acid has 6 to 18 carbons.

  本发明提供了一种用于口服的免疫原组合物，该组合物包含一种免疫原和一种或多种蔗糖脂肪酸酯，其中脂肪酸具有 6 至 18 个碳原子。
• Compositions containing aliphatic monocarboxylic acid esters or amides for the treatment of skin diseases
  申请人：CELLEGY PHARMACEUTICALS, INC.

  公开号：EP0839529A2

  公开（公告）日：1998-05-06

  Skin conditions characterized by hyperactive mitochondria including inflammatory, hyperproliferative, hyperplastic, and dysplastic skin cells are treated with topical formulations of 5 to 19 carbon atom length aliphatic monocarboxylic acid esters or amides, as well as 5 to 19 carbon atom length monoaliphatic amines or their pharmaceutically acceptable salts.

  以线粒体功能亢进为特征的皮肤病，包括炎症性、增生性、增生性和发育不良性皮肤细胞，可使用 5 至 19 个碳原子长度的脂肪族单羧酸酯或酰胺，以及 5 至 19 个碳原子长度的单脂肪胺或它们的药学上可接受的盐类的外用制剂进行治疗。
• LEUKOCYTE ANALYSIS METHOD AND ANALYSIS REAGENT FOR USE IN THE METHOD
  申请人：ARKRAY, Inc.

  公开号：EP2278331A1

  公开（公告）日：2011-01-26

  The present invention provides a method for analyzing leukocytes, by which the leukocytes can be classified and measured stably with high accuracy even when a dilution ratio of a sample containing the leukocytes is low or a flow velocity during the analysis is slow, and an analysis reagent used for the analysis method. The analysis method of the present invention includes the steps of mixing a sample containing leukocytes and erythrocytes and an analysis reagent containing a surfactant that reacts with leukocytes; and measuring the leukocytes by passing a mixed solution of the sample and the analysis reagent through a fine through-hole, measuring a signal detected when the mixed solution passes through the fine through-hole, and classifying and counting the leukocytes in the sample. The analysis reagent further contains a nonionic surfactant, and the nonionic surfactant has a sugar residue as a hydrophilic region and an aliphatic chain as a hydrophobic region.

  本发明提供了一种分析白细胞的方法，通过该方法，即使含有白细胞的样品的稀释率较低或分析过程中流速较慢，也能稳定地对白细胞进行分类和测量，且准确度高；本发明还提供了一种用于该分析方法的分析试剂。本发明的分析方法包括以下步骤：将含有白细胞和红细胞的样品与含有能与白细胞反应的表面活性剂的分析试剂混合；通过将样品和分析试剂的混合溶液通过细通孔，测量混合溶液通过细通孔时检测到的信号，并对样品中的白细胞进行分类和计数，从而测量白细胞。分析试剂还含有非离子表面活性剂，非离子表面活性剂的亲水区域为糖残基，疏水区域为脂肪族链。
• Method for treating a blood component containing sample
  申请人：ARKRAY, Inc.

  公开号：EP2677317A1

  公开（公告）日：2013-12-25

  Provided is a treatment method for damaging an erythrocyte and a leukocyte while suppressing damage to cells other than blood cells present in blood. In an embodiment, the disclosure relates to a method for treating a sample containing blood components, the method including mixing a sample containing blood components with a surfactant A, where the surfactant A is a nonionic surfactant represented by General formula R1-O-(EO)n-R2 (I).

  本发明提供了一种在抑制对血液中血细胞以外的细胞造成损伤的同时，对红细胞和白细胞造成损伤的处理方法。在一个实施方案中，本公开涉及一种处理含有血液成分的样品的方法，该方法包括将含有血液成分的样品与表面活性剂 A 混合，其中表面活性剂 A 是通式 R1-O-(EO)n-R2 (I) 所代表的非离子表面活性剂。